Romosozumab, also known as Evenity, is a medication used to treat osteoporosis in postmenopausal women who are at high risk of fractures. It works by increasing bone density and strength, ultimately decreasing the risk of fractures. The recommended dosage is 210 mg/2.34 ml (105 mg/1.17 x 2) administered as a subcutaneous injection once a month. The optimal time to take this medication is determined by your healthcare provider.
b908
source
